Microsoft Technology Licensing, LLC

Sandoz Ag

Amit Gupta

Sumit Chatterjee

Prashant Raj Bhugra

Avishek Mazumder

Akash Vijay Lingayat

Neeraj Sharma

Vivek Jain

Vivek Battu

Anandkrishna Laxmikant Kulkanri

Shilpa Gopinathan Nair

Aspects of the present disclosure relate to modularizing and embedding modules across a variety of web applications. More specifically, the present disclosure provides an adaptive UI module to web application servers that adapts its format upon evaluating an environment of the web application and receiving a user request for supplemental information. For example, a single adaptive UI module may be used across a variety of web applications, with a variety of requests for supplemental content from within each web application, to generate multiple, unique formatted UI modules. In this way, a single adaptive UI module may generate formatted UI modules specific to the formatting requirements of each requesting web application, with supplemental content related to each unique user request from within each web application.

Modularizing and embedding supplemental textual and visual content in different environments

A pharmaceutical formulation is disclosed which includes at least: (1) elagolix sodium, (2) magnesium oxide, and (3) at least one disintegrating agent, such as crospovidone, croscarmellose sodium, sodium starch glycolate, pregelatinized and mixtures thereof. A tablet is also disclosed which includes a tablet core formed from the pharmaceutical formulation. The elagolix sodium tablets of the present disclosure display improved dissolution rates when tested using for example the Tablet Sink Time test. The tablets also exhibit improved storage stability of the elagolix sodium, with a reduction in degradation products during storage.

Elagolix formulation

Growing community of inventors

Hyderabad Telangana, India

Amit Gupta